IL15 and neoplasm: Recognizing these challenges, we adopted a strategy of co-loading CAR-T cells with IL-15 and CCL19, expecting that this approach would facilitate the migration and infiltration of CAR-T cells into the tumor site while also supporting their sustained expansion and anti-tumor functionality within the TME.